tirzepatide weight loss injection vs. Semaglutide for Semaglutide vs Tirzepatide for Weight

However, notable weight loss was observed in the early dose-titration group

Mattivi, U

In a landmark trial of 17,604 overweight and obese patients with heart disease, weekly injections of semaglutidethe active ingredient in Wegovy and its twin Ozempicfor an average of 33 months reduced the risk of heart attack, stroke, and death from cardiovascular causes by 20 percent compared with a placebo group

Learn More From MICC and Myers Cocktail to B12, biotin, mineral blends, and high-dose vitamin C, our injections deliver essential nutrients directly where your body needs them most

Typically, GI side effects of GLP-1s such as nausea and vomiting are dose-dependent, mild-to-moderate in severity and occur mostly during initiation of therapy and up-titration

Available at: Last accessed: 16 March 2026